Drug Database
Back to search

Netherlands· NL-1a57fbe07820

Pluvicto 1.000 MBq/ml oplossing voor injectie/infusie

A lutetium (177lu) vipivotide tetraxetan product containing lutetium (177lu) vipivotide tetraxetan, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 9 of our 19 countries.

ATC V10XX05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPluvicto 1.000 MBq/ml oplossing voor …ATCV10XX05REGISTER NO.NL-1a57fbe07820PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lutetium (177lu) vipivotide tetraxetanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lutetium (177lu) vipivotide tetraxetan is registered in 9 of 19 countries.

Countries holding a registration under ATC V10XX05 (lutetium (177lu) vipivotide tetraxetan), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search lutetium (177lu) vipivotide tetraxetan products by name

Lutetium (177lu) vipivotide tetraxetan · ATC V10XX05

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
Manufacturer
Novartis Europharm Limited
Country
Netherlands (NL)
ATC code
V10XX05
ATC class
Lutetium (177Lu) vipivotide tetraxetan
Defined daily dose
176 MBq, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/22/1703

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lutetium (177lu) vipivotide tetraxetan in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lutetium (177lu) vipivotide tetraxetan products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Pluvicto
  • Liechtenstein · Pluvicto
  • Norway · Pluvicto

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/63fd3da5-9ab0-4833-9106-6b7ce88c0870
GET /v1/drugs/63fd3da5-9ab0-4833-9106-6b7ce88c0870?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie of infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/pluvicto-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Lutetium (177 Lu) Vipivotide Tetraxetan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129055",
  "excipients": [
    "AZIJNZUUR (E 260)",
    "GENTISINEZUUR",
    "NATRIUMACETAAT 0-WATER (E 262)",
    "NATRIUMASCORBAAT (E 301)",
    "PENTETINEZUUR",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2022/12/09",
  "procedure_number": "EMEA/H/C/005483",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/22/1703",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about lutetium (177lu) vipivotide tetraxetan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console